Should platelets be transfused in thrombocytopenic patients before central line placement?
In hematologic malignancies, yes; PACER trial provides limited insight otherwise
Central venous catheterization (CVC or central lines), when placed with ultrasound guidance, have a low rate of severe bleeding complications, even in patients with significant thrombocytopenia. Nevertheless, platelets are frequently transfused prior to CVC placement in patients with platelet counts 20,000-50,000/mcL. Is this justified?
The PACER trial r…
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.